HENRY VANPALA: Open Payments
NPI 1023518339 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,835 in 257 payments from 32 companies in 2025. Trend: 2023 $5,531 · 2024 $4,786 · 2025 $14,835
Speaker / faculty: $9,325Food & beverage: $4,737Travel & lodging: $644Education: $129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $6,986 |
| Amgen Inc. | 27 | $3,811 |
| Axsome Therapeutics, Inc. | 27 | $525 |
| TOLMAR, INC. | 14 | $352 |
| Novo Nordisk Inc | 19 | $344 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $240 |
| AstraZeneca Pharmaceuticals LP | 10 | $238 |
| PFIZER INC. | 14 | $228 |
| Janssen Pharmaceuticals, Inc | 9 | $224 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $212 |
Products named: UBRELVY, REPATHA, QULIPTA, JATENZO, REXULTI, Wegovy, Auvelity, XIFAXAN.
Industry payments across NC — which companies pay providers there.
